Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial. - Combs,S.E.; Kieser,M.; Rieken,S. (BMC Cancer, 2010)